187 related articles for article (PubMed ID: 28760546)
21. Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options.
de Cássia Orlandi Sardi J; Silva DR; Soares Mendes-Giannini MJ; Rosalen PL
Microb Pathog; 2018 Dec; 125():116-121. PubMed ID: 30205192
[TBL] [Abstract][Full Text] [Related]
22. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen.
Forsberg K; Woodworth K; Walters M; Berkow EL; Jackson B; Chiller T; Vallabhaneni S
Med Mycol; 2019 Jan; 57(1):1-12. PubMed ID: 30085270
[TBL] [Abstract][Full Text] [Related]
23. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008).
Tortorano AM; Dho G; Prigitano A; Breda G; Grancini A; Emmi V; Cavanna C; Marino G; Morero S; Ossi C; Delvecchio G; Passera M; Cusumano V; David A; Bonaccorso G; Corona A; Favaro M; Vismara C; Garau MG; Falchi S; Tejada MR;
Mycoses; 2012 Jan; 55(1):73-9. PubMed ID: 21668521
[TBL] [Abstract][Full Text] [Related]
24. Pan-resistant Candida auris isolates from the outbreak in New York are susceptible to ibrexafungerp (a glucan synthase inhibitor).
Zhu YC; Barat SA; Borroto-Esoda K; Angulo D; Chaturvedi S; Chaturvedi V
Int J Antimicrob Agents; 2020 Apr; 55(4):105922. PubMed ID: 32092395
[No Abstract] [Full Text] [Related]
25. Candida auris: report of an outbreak.
García CS; Palop NT; Bayona JVM; García MM; Rodríguez DN; Álvarez MB; Serrano MDRG; Cardona CG
Enferm Infecc Microbiol Clin (Engl Ed); 2020 Jan; 38 Suppl 1():39-44. PubMed ID: 32111364
[TBL] [Abstract][Full Text] [Related]
26. Attack, Defend and Persist: How the Fungal Pathogen Candida auris was Able to Emerge Globally in Healthcare Environments.
de Jong AW; Hagen F
Mycopathologia; 2019 Jun; 184(3):353-365. PubMed ID: 31209693
[TBL] [Abstract][Full Text] [Related]
27. Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.
De Francesco MA; Piccinelli G; Gelmi M; Gargiulo F; Ravizzola G; Pinsi G; Peroni L; Bonfanti C; Caruso A
Mycopathologia; 2017 Oct; 182(9-10):897-905. PubMed ID: 28597394
[TBL] [Abstract][Full Text] [Related]
28. Candida auris outbreak: Mortality, interventions and cost of sustaining control.
Taori SK; Khonyongwa K; Hayden I; Athukorala GDA; Letters A; Fife A; Desai N; Borman AM
J Infect; 2019 Dec; 79(6):601-611. PubMed ID: 31557493
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiological profile and sensitivity pattern of isolates causing invasive fungal infection vs. colonizing isolates in non-neutropenic critically ill patients].
Serrano R; Gimeno A; Plumed L; Pemán J; Alvarez B; Plazas J; Caturla J
Rev Iberoam Micol; 2013 Jan; 30(1):14-20. PubMed ID: 22749973
[TBL] [Abstract][Full Text] [Related]
30. Changes in the epidemiological landscape of invasive candidiasis.
Lamoth F; Lockhart SR; Berkow EL; Calandra T
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i4-i13. PubMed ID: 29304207
[TBL] [Abstract][Full Text] [Related]
31. Etiology of invasive candidosis agents in Russia: a multicenter epidemiological survey.
Vasilyeva NV; Raush ER; Rudneva MV; Bogomolova TS; Taraskina AE; Fang Y; Zhang F; Klimko NN
Front Med; 2018 Feb; 12(1):84-91. PubMed ID: 29335835
[TBL] [Abstract][Full Text] [Related]
32. Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment.
Arendrup MC; Patterson TF
J Infect Dis; 2017 Aug; 216(suppl_3):S445-S451. PubMed ID: 28911043
[TBL] [Abstract][Full Text] [Related]
33. Recent advances and future perspectives in the pharmacological treatment of
Giacobbe DR; Magnasco L; Sepulcri C; Mikulska M; Koehler P; Cornely OA; Bassetti M
Expert Rev Clin Pharmacol; 2021 Oct; 14(10):1205-1220. PubMed ID: 34176393
[TBL] [Abstract][Full Text] [Related]
34. A Candida auris Outbreak and Its Control in an Intensive Care Setting.
Eyre DW; Sheppard AE; Madder H; Moir I; Moroney R; Quan TP; Griffiths D; George S; Butcher L; Morgan M; Newnham R; Sunderland M; Clarke T; Foster D; Hoffman P; Borman AM; Johnson EM; Moore G; Brown CS; Walker AS; Peto TEA; Crook DW; Jeffery KJM
N Engl J Med; 2018 Oct; 379(14):1322-1331. PubMed ID: 30281988
[TBL] [Abstract][Full Text] [Related]
35. A high-throughput and rapid method for accurate identification of emerging multidrug-resistant Candida auris.
Ahmad A; Spencer JE; Lockhart SR; Singleton S; Petway DJ; Bagarozzi DA; Herzegh OT
Mycoses; 2019 Jun; 62(6):513-518. PubMed ID: 30801778
[TBL] [Abstract][Full Text] [Related]
36. Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan?
Lu PL; Liu WL; Lo HJ; Wang FD; Ko WC; Hsueh PR; Ho MW; Liu CE; Chen YH; Chen YC; Chuang YC; Chang SC
J Formos Med Assoc; 2018 Jun; 117(6):462-470. PubMed ID: 29122404
[TBL] [Abstract][Full Text] [Related]
37. Invasive Candidiasis.
Kullberg BJ; Arendrup MC
N Engl J Med; 2015 Oct; 373(15):1445-56. PubMed ID: 26444731
[No Abstract] [Full Text] [Related]
38. Epidemiology of candidaemia and invasive candidiasis. A changing face.
Quindós G
Rev Iberoam Micol; 2014; 31(1):42-8. PubMed ID: 24270071
[TBL] [Abstract][Full Text] [Related]
39. Recognition and diagnosis of invasive fungal infections in neonates.
Calley JL; Warris A
J Infect; 2017 Jun; 74 Suppl 1():S108-S113. PubMed ID: 28646949
[TBL] [Abstract][Full Text] [Related]
40. Single-tube, dual channel pentaplexing for the identification of Candida strains associated with human infection.
Jainlabdin MH; Batra A; Sánchez Paredes E; Hernández Hernández F; Fu G; Tovar-Torres J
Sci Rep; 2019 Oct; 9(1):14692. PubMed ID: 31604994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
